About Neuropraxis München Süd
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Biogen
4
H. Lundbeck A/S
1
Clinical Trials at Neuropraxis München Süd
During the past decade, Neuropraxis München Süd conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
2015-09-15
2019-08-05
Terminated
1,643
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
2020-03-02
2025-02-03
Active, not recruiting
1,696
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
2020-06-01
2022-09-15
Completed
892
Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study
2021-07-01
2023-12-01
Recruiting
200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Neuropraxis München Süd
According to Clinical.Site data, the most researched conditions in "Neuropraxis München Süd" are
"Alzheimer's Disease" (2 trials), "Migraine" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Relapsing-Remitting Multiple Sclerosis (RRMS)" (1 trials). Many other conditions were trialed in "Neuropraxis München Süd" in a lesser frequency.
Clinical Trials Intervention Types at Neuropraxis München Süd
Most popular intervention types in "Neuropraxis München Süd" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Aducanumab" (1 trials), "Aducanumab (BIIB037)" (1 trials), "Eptinezumab" (1 trials) and "Natalizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Neuropraxis München Süd
The vast majority of trials in "Neuropraxis München Süd" are
5 trials for "All" genders.
Clinical Trials Status at Neuropraxis München Süd
Currently, there are NaN active trials in "Neuropraxis München Süd".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Neuropraxis München Süd,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Neuropraxis München Süd, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".